New Delhi, Oct. 30 -- Indian multinational pharmaceutical giant, Cipla, shares dropped more than 4% during the intraday trading session on Thursday, 30 October 2025, after the company announced its July-September quarter results and the MD and global CEO announced his plans to leave the company at the end of his term.

In an official filing on Thursday, Cipla's Managing Director (MD) and global Chief Executive Officer (CEO), Umang Vohra, disclosed that he is not seeking reappointment for his role after the term ends on 31 March 2026.

"Umang Vohra (DIN: 02296740), Managing Director & Global Chief Executive Officer (MD & GCEO), expressed his intention to not seek re-appointment as Managing Director & Global Chief Executive Officer of the C...